UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Effect of overnight constant infusion of human growth hormone (GH)-releasing hormone-(1-44) on 24-hour GH secretion in children with partial GH deficiency

The journal of clinical endocrinology and metabolism, 1986-11, Vol.63 (5), p.1100-1105

1986

Volltextzugriff (PDF)

Results of 1-year growth hormone (GH)-releasing hormone-(1-44) treatment on growth, somatomedin-C, and 24-hour GH secretion in six children with partial GH deficiency

The journal of clinical endocrinology and metabolism, 1987-08, Vol.65 (2), p.268-274

1987

Volltextzugriff (PDF)

Effects of human growth hormone therapy on melanocytic naevi

The Lancet (British edition), 1993-06, Vol.341 (8859), p.1505-1506

1993

Volltextzugriff (PDF)

A 5-year prospective study of growth hormone (GH)-deficient children treated with GH before the age of 3 years

The journal of clinical endocrinology and metabolism, 1997-02, Vol.82 (2), p.452-456

1997

Volltextzugriff (PDF)

Recurrent ovarian cyst and mutation of the Gsα gene in ovarian cyst fluid cells: what is the link with McCune‐Albright syndrome?

Acta Paediatrica, 1997-09, Vol.86 (9), p.1019-1021

1997

Volltextzugriff (PDF)

Growth hormone, insulin-like growth factor-I and insulin-like growth factor binding protein-3 are regulated differently in small-for-gestational-age and appropriate-for-gestational-age neonates

Biology of the neonate, 1998-06, Vol.73 (6), p.347-355

1998

Volltextzugriff (PDF)

Differential regulation of serum growth hormone (GH)-binding protein during continuous infusion versus daily injection of recombinant human GH in GH-deficient children

The journal of clinical endocrinology and metabolism, 1993-05, Vol.76 (5), p.1135-1139

1993

Volltextzugriff (PDF)

Evaluation of cutaneous modifications in seventy-seven growth hormone-deficient children

Hormone research, 2000-01, Vol.54 (2), p.92-97

2000

Volltextzugriff (PDF)

A thyroxine dosage of 8 μg/kg per day is appropriate for the initial treatment of the majority of infants with congenital hypothyroidism

European journal of pediatrics, 1997-02, Vol.156 (2), p.94-98

1997

Volltextzugriff (PDF)

Human growth hormone receptor: cloning and expression of the full-length complementary DNA after site-directed inactivation of a cryptic bacterial promoter

Gene, 1997-07, Vol.194 (1), p.97-105

1997

Volltextzugriff (PDF)

Guidelines for neonatal screening programmes for congenital hypothyroidism

European journal of pediatrics, 1993-12, Vol.152 (12), p.974-975

1993

Volltextzugriff (PDF)

Improvement of diagnostic criteria in growth hormone insensitivity syndrome: solutions and pitfalls

Acta Paediatrica, 1994-04, Vol.83 (s399), p.117-124

1994

Volltextzugriff (PDF)

Heterozygous mutation in the WSXWS equivalent motif of the growth hormone receptor in a child with poor response to growth hormone therapy

Growth hormone & IGF research, 1998-06, Vol.8 (3), p.211-216

1998

Volltextzugriff (PDF)

A 5-year prospective study of growth hormone (GH)-deficient children treated with GH before the age of 3 years. French Serono Study Group

The journal of clinical endocrinology and metabolism, 1997-02, Vol.82 (2), p.452-456

1997

Volltextzugriff (PDF)

Expression of a recombinant human growth hormone binding protein in baculovirus/insect cell system

Biochimie, 1996, Vol.78 (10), p.882-886

1996

Volltextzugriff (PDF)

Guidelines for Neonatal Screening Programs for Congenital Hypothyroidism

Hormone research, 1994, Vol.41 (1), p.1-2

1994

Volltextzugriff (PDF)

Heterozygous mutation in the WSXWS equivalaent motif of the growth hormone receptor in a child with poor response to growth hormone therapy

Growth hormone & IGF research, 1998-06, Vol.8 (3), p.211-216

1998

Volltextzugriff (PDF)

A thyroxine dosage of 8 micrograms/kg per day is appropriate for the initial treatment of the majority of infants with congenital hypothyroidism

European journal of pediatrics, 1997-02, Vol.156 (2), p.94-98

1997

Volltextzugriff (PDF)

A thyroxine dosage of 8 [mu]g/kg per day is appropriate for the initial treatment of the majority of infants with congenital hypothyroidism

European journal of pediatrics, 1997-01, Vol.156 (2), p.94

1997

Volltextzugriff (PDF)

Molecular analysis of the androgen receptor gene in 52 patients with complete or partial androgen insensitivity syndrome: a collaborative study

Hormone research, 1992-01, Vol.37 (1-2), p.54-59

1992

Volltextzugriff (PDF)

Growth hormone treatment in patients with neurosecretory dysfunction

Hormone research, 1990-01, Vol.33 Suppl 4 (4), p.97-101

1990

Volltextzugriff (PDF)

Culture of islets of Langerhans from an infant with intractable neonatal hypoglycemia: cytochemical and radioimmunological studies

Diabete & metabolisme, 1989-09, Vol.15 (5), p.261

1989

Volltextzugriff (PDF)

Growth hormone insensitivity syndromes: a preliminary report on changes in insulin-like growth factors and their binding proteins during treatment with recombinant insulin-like growth factor I

Acta Paediatrica, 1993-12, Vol.82 (s392), p.15-19

1993

Volltextzugriff (PDF)

Mise en évidence de mutations du gène du récepteur de l'hormone de croissance chez des enfants « mauvais répondeursau traitement par l'hormone de croissance recombinante

Archives de pédiatrie : organe officiel de la Société française de pédiatrie, 1997, Vol.4, p.201s-201s

1997

Volltextzugriff (PDF)

Results of treatment with recombinant human insulin-like growth factor I

Acta Paediatrica, 1994-04, Vol.83 (s399), p.142-142

Wilton, P

1994

Volltextzugriff (PDF)

1 – 25 von 30

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(26)
Mit Volltextzugriff
(20)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Effect of overnight constant infusion of human growth hormone (GH)-releasing hormone-(1-44) on 24-hour GH secretion in children with partial GH deficiency

Results of 1-year growth hormone (GH)-releasing hormone-(1-44) treatment on growth, somatomedin-C, and 24-hour GH secretion in six children with partial GH deficiency

Effects of human growth hormone therapy on melanocytic naevi

A 5-year prospective study of growth hormone (GH)-deficient children treated with GH before the age of 3 years

Recurrent ovarian cyst and mutation of the Gsα gene in ovarian cyst fluid cells: what is the link with McCune‐Albright syndrome?

Growth hormone, insulin-like growth factor-I and insulin-like growth factor binding protein-3 are regulated differently in small-for-gestational-age and appropriate-for-gestational-age neonates

Differential regulation of serum growth hormone (GH)-binding protein during continuous infusion versus daily injection of recombinant human GH in GH-deficient children

Evaluation of cutaneous modifications in seventy-seven growth hormone-deficient children

A thyroxine dosage of 8 μg/kg per day is appropriate for the initial treatment of the majority of infants with congenital hypothyroidism

Human growth hormone receptor: cloning and expression of the full-length complementary DNA after site-directed inactivation of a cryptic bacterial promoter

Guidelines for neonatal screening programmes for congenital hypothyroidism

Improvement of diagnostic criteria in growth hormone insensitivity syndrome: solutions and pitfalls

Heterozygous mutation in the WSXWS equivalent motif of the growth hormone receptor in a child with poor response to growth hormone therapy

A 5-year prospective study of growth hormone (GH)-deficient children treated with GH before the age of 3 years. French Serono Study Group

Expression of a recombinant human growth hormone binding protein in baculovirus/insect cell system

Guidelines for Neonatal Screening Programs for Congenital Hypothyroidism

Heterozygous mutation in the WSXWS equivalaent motif of the growth hormone receptor in a child with poor response to growth hormone therapy

A thyroxine dosage of 8 micrograms/kg per day is appropriate for the initial treatment of the majority of infants with congenital hypothyroidism

A thyroxine dosage of 8 [mu]g/kg per day is appropriate for the initial treatment of the majority of infants with congenital hypothyroidism

Molecular analysis of the androgen receptor gene in 52 patients with complete or partial androgen insensitivity syndrome: a collaborative study

Growth hormone treatment in patients with neurosecretory dysfunction

Culture of islets of Langerhans from an infant with intractable neonatal hypoglycemia: cytochemical and radioimmunological studies

Growth hormone insensitivity syndromes: a preliminary report on changes in insulin-like growth factors and their binding proteins during treatment with recombinant insulin-like growth factor I

Mise en évidence de mutations du gène du récepteur de l'hormone de croissance chez des enfants « mauvais répondeursau traitement par l'hormone de croissance recombinante

Results of treatment with recombinant human insulin-like growth factor I

Suchergebnisse filtern